CuraFlo™ is a cold plasma microbial remediation system for post-harvest flower and botanicals. For licensed producers, processors, importers and labs in Poland, it knocks down total yeast and mold (TYMC) and bacteria without heat, chemicals, ozone residue or ionizing radiation, so at-risk and out-of-spec lots can be recovered, retested and released instead of destroyed.
Microbial quality in Poland’s cannabis market
Poland’s medical market has grown fast and is supplied largely by imported pharmaceutical flower. Distributors and importers holding product against strict release specs are high-value partners for remediation.
Cannabis in Poland is regulated by the Office for Registration of Medicinal Products (URPL) and the Chief Pharmaceutical Inspectorate (GIF), which sets or enforces microbial specifications and the rules for treating and releasing product. One failed microbial result can cost $50K to $500K in destroyed product, lost contracts and re-testing.
Why lots fail yeast and mold specs in Poland
- Humidity spikes during late flower, drying and cure
- Dense canopies and limited airflow in grow and dry rooms
- Handling, trimming and packaging contamination
- Long transit and storage times for export and import lots
- Tight pharmaceutical release specs with no room for error
How CuraFlo™ helps operators in Poland
- >99.8% TYMC reduction validated across batches VAL-001 to VAL-003
- <0.2% THC variance: potency, terpenes, color and bag appeal stay intact
- No heat, no chemicals, no ozone residue, no ionizing radiation
- No radioactive sources, no shielding, no hazmat handling
- Documented, repeatable cycle logs for your quality system and SOPs
- About $60K USD list, with lease and financing options
Best fit in Poland: Validated decontamination for pharmaceutical-grade supply
Pharmaceutical-grade markets demand that every step is validated and documented. CuraFlo™ gives you a repeatable, logged cycle to build into your quality system, with validation data (VAL-001 to VAL-003) to start that work.
Who we work with in Poland
- Licensed producers and cultivators
- Processors, manufacturers and EU-GMP or GMP facilities
- Importers, exporters and distributors holding out-of-spec stock
- Testing labs that want a recovery path for clients
How it works
- Baseline: we run an R&D pass on your microbial panel to set cycle parameters
- Treat: product runs through CuraFlo™ cold plasma cycles
- Retest: your lab runs release testing per your specs
- Document: cycle logs become part of your SOP and quality records
Poland cold plasma remediation FAQ
Is cold plasma remediation allowed in Poland?
Cannabis quality rules in Poland are set by the Office for Registration of Medicinal Products (URPL) and the Chief Pharmaceutical Inspectorate (GIF). Any decontamination or remediation step generally has to be validated in your quality system, accepted by your regulator or in your product approval, and followed by release testing. We provide cycle data and process documentation to support that review. Confirm current requirements with your regulator before treating product for sale.
Does CuraFlo™ affect potency or terpenes?
Validation batches VAL-001 to VAL-003 showed less than 0.2% THC variance. The process runs without heat, so terpenes, color and bag appeal stay intact.
Is CuraFlo™ an irradiation process?
No. CuraFlo™ is cold plasma, not gamma, X-ray or e-beam. No ionizing radiation, no radioactive sources, no shielding and no hazmat handling.
Can you ship CuraFlo™ to Poland?
Yes, we quote international orders per country. The system lists at about $60,000 USD; international quotes cover shipping, power requirements and import documentation. Lease and financing options are available.
Talk to an operator, not a salesperson
CuraFlo™ is backed by 15+ years in the cannabis industry and 200+ dispensary and cultivation transactions through Canna 1 Advisors. Book a 15-minute ROI call and we’ll run the numbers on your Poland operation.
See cannabis remediation in other countries · U.S. states
Cannabis quality and decontamination rules vary by country and change often. Confirm current requirements with the Office for Registration of Medicinal Products (URPL) and the Chief Pharmaceutical Inspectorate (GIF) before treating product for sale. CuraFlo™ does not make health claims and does not guarantee testing outcomes.